D-0938-2023 Class I Terminated
FDA drug recall D-0938-2023 was initiated by Cipla USA, Inc. on Jun 27, 2023 and is designated Class I. Reason for recall: Defective container: empty inhaler and leakage observed through the inhaler valve due to partially missing bottom seat (gasket). The recall status is terminated (terminated Mar 6, 2025). Affected quantity: 278,538 canisters.
Recall details
- Product Type
- Drugs
- Report Date
- Jul 19, 2023
- Initiation Date
- Jun 27, 2023
- Termination Date
- Mar 6, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 278,538 canisters
Product description
Albuterol Sulfate Inhalation Aerosol, 90 mcg, 200 Metered Inhalation, net content 6.7 g canister packaged in a box, Rx only, Manufactured by: Cipla Ltd, Indore SE Z, Pithampur, India, Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ, 07059, NDC 69097-142-60
Reason for recall
Defective container: empty inhaler and leakage observed through the inhaler valve due to partially missing bottom seat (gasket).
Distribution pattern
Nationwide in the US
Code information
Lot # IB20045, IB20055, IB20056, IB20057, IB20059, IB20072, Exp Nov. 30, 2023
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0938-2023
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026